(SBS) Companhia de Saneamento - Ratings and Ratios
Water, Sewage, Treatment, Connections
SBS EPS (Earnings per Share)
SBS Revenue
Description: SBS Companhia de Saneamento October 30, 2025
Companhia de Saneamento Básico do Estado de São Paulo (SABESP, NYSE:SBS) is Brazil’s largest water-and-sewage utility, serving 9.5 million water connections and 8.2 million sewage connections across 375 municipalities in São Paulo State as of 31 Dec 2024.
Key recent metrics: • 2024 revenue of R$ 30.2 bn, up 3.5 % YoY, driven by modest tariff adjustments approved by the state regulator. • Adjusted EBITDA margin stabilized around 45 % after a 2023-24 capital-intensive expansion phase. • Net debt/EBITDA ratio sits at 2.1×, reflecting a disciplined refinancing program that extended maturities to 2029.
Primary economic and sector drivers: • Brazil’s inflation-linked tariff regime allows periodic water-price increases, which historically boost top-line growth in line with CPI (average 4.2 % YoY over the past five years). • Ongoing urbanization and population growth in São Paulo (≈ 12 million new residents projected by 2030) raise demand for both water supply and sewage treatment. • Government-mandated universal access targets spur capital-intensive projects, creating a pipeline of roughly R$ 15 bn in approved investments through 2027.
If you want a data-rich, scenario-based assessment of SABESP’s valuation and risk profile, the ValueRay platform provides a structured deep-dive that can help sharpen your investment thesis.
SBS Stock Overview
| Market Cap in USD | 16,555m | 
| Sub-Industry | Water Utilities | 
| IPO / Inception | 2002-05-10 | 
SBS Stock Ratings
| Growth Rating | 96.5% | 
| Fundamental | 82.1% | 
| Dividend Rating | 56.1% | 
| Return 12m vs S&P 500 | 32.8% | 
| Analyst Rating | 4.50 of 5 | 
SBS Dividends
| Dividend Yield 12m | 2.68% | 
| Yield on Cost 5y | 9.82% | 
| Annual Growth 5y | 2.76% | 
| Payout Consistency | 74.6% | 
| Payout Ratio | 23.8% | 
SBS Growth Ratios
| Growth Correlation 3m | 79% | 
| Growth Correlation 12m | 92.8% | 
| Growth Correlation 5y | 94.6% | 
| CAGR 5y | 31.83% | 
| CAGR/Max DD 3y (Calmar Ratio) | 1.34 | 
| CAGR/Mean DD 3y (Pain Ratio) | 4.43 | 
| Sharpe Ratio 12m | 1.77 | 
| Alpha | 50.99 | 
| Beta | 0.157 | 
| Volatility | 28.89% | 
| Current Volume | 937.6k | 
| Average Volume 20d | 834.2k | 
| Stop Loss | 23.7 (-3.2%) | 
| Signal | 0.39 | 
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (11.99b TTM) > 0 and > 6% of Revenue (6% = 2.81b TTM) | 
| FCFTA 0.10 (>2.0%) and ΔFCFTA 3.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) | 
| NWC/Revenue 5.92% (prev 9.63%; Δ -3.70pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) | 
| CFO/TA 0.10 (>3.0%) and CFO 8.52b <= Net Income 11.99b (YES >=105%, WARN >=100%) | 
| Net Debt (26.72b) to EBITDA (21.23b) ratio: 1.26 <= 3.0 (WARN <= 3.5) | 
| Current Ratio 1.26 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) | 
| Outstanding Shares last Quarter (683.5m) change vs 12m ago 0.0% (target <= -2.0% for YES) | 
| Gross Margin 48.24% (prev 40.30%; Δ 7.93pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) | 
| Asset Turnover 61.00% (prev 41.79%; Δ 19.21pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) | 
| Interest Coverage Ratio 37.96 (EBITDA TTM 21.23b / Interest Expense TTM 514.6m) >= 6 (WARN >= 3) | 
Altman Z'' 2.93
| (A) 0.03 = (Total Current Assets 13.23b - Total Current Liabilities 10.46b) / Total Assets 88.72b | 
| (B) 0.04 = Retained Earnings (Balance) 3.62b / Total Assets 88.72b | 
| (C) 0.25 = EBIT TTM 19.53b / Avg Total Assets 76.70b | 
| (D) 0.84 = Book Value of Equity 40.44b / Total Liabilities 48.28b | 
| Total Rating: 2.93 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) | 
ValueRay F-Score (Strict, 0-100) 82.08
| 1. Piotroski 8.0pt = 3.0 | 
| 2. FCF Yield 7.53% = 3.76 | 
| 3. FCF Margin 18.06% = 4.52 | 
| 4. Debt/Equity 0.77 = 2.21 | 
| 5. Debt/Ebitda 1.26 = 1.37 | 
| 6. ROIC - WACC (= 14.77)% = 12.50 | 
| 7. RoE 31.20% = 2.50 | 
| 8. Rev. Trend 70.39% = 5.28 | 
| 9. EPS Trend -61.35% = -3.07 | 
What is the price of SBS shares?
Over the past week, the price has changed by +0.62%, over one month by +0.04%, over three months by +25.41% and over the past year by +57.53%.
Is Companhia de Saneamento a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SBS is around 31.11 USD . This means that SBS is currently undervalued and has a potential upside of +27.08% (Margin of Safety).
Is SBS a buy, sell or hold?
- Strong Buy: 3
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SBS price?
| Issuer | Target | Up/Down from current | 
|---|---|---|
| Wallstreet Target Price | 25.1 | 2.4% | 
| Analysts Target Price | 25.1 | 2.4% | 
| ValueRay Target Price | 33.6 | 37.4% | 
SBS Fundamental Data Overview October 22, 2025
P/E Trailing = 8.0199
P/E Forward = 11.5207
P/S = 0.4115
P/B = 2.1543
P/EG = 2.55
Beta = 0.157
Revenue TTM = 46.79b BRL
EBIT TTM = 19.53b BRL
EBITDA TTM = 21.23b BRL
Long Term Debt = 27.74b BRL (from longTermDebt, last quarter)
Short Term Debt = 3.32b BRL (from shortTermDebt, last quarter)
Debt = 31.28b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 26.72b BRL (from netDebt column, last quarter)
Enterprise Value = 112.31b BRL (88.95b + Debt 31.28b - CCE 7.93b)
Interest Coverage Ratio = 37.96 (Ebit TTM 19.53b / Interest Expense TTM 514.6m)
FCF Yield = 7.53% (FCF TTM 8.45b / Enterprise Value 112.31b)
FCF Margin = 18.06% (FCF TTM 8.45b / Revenue TTM 46.79b)
Net Margin = 25.62% (Net Income TTM 11.99b / Revenue TTM 46.79b)
Gross Margin = 48.24% ((Revenue TTM 46.79b - Cost of Revenue TTM 24.22b) / Revenue TTM)
Gross Margin QoQ = 41.82% (prev 41.78%)
Tobins Q-Ratio = 1.27 (Enterprise Value 112.31b / Total Assets 88.72b)
Interest Expense / Debt = 1.55% (Interest Expense 484.7m / Debt 31.28b)
Taxrate = 33.83% (1.09b / 3.23b)
NOPAT = 12.93b (EBIT 19.53b * (1 - 33.83%))
Current Ratio = 1.26 (Total Current Assets 13.23b / Total Current Liabilities 10.46b)
Debt / Equity = 0.77 (Debt 31.28b / totalStockholderEquity, last quarter 40.44b)
Debt / EBITDA = 1.26 (Net Debt 26.72b / EBITDA 21.23b)
Debt / FCF = 3.16 (Net Debt 26.72b / FCF TTM 8.45b)
Total Stockholder Equity = 38.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.51% (Net Income 11.99b / Total Assets 88.72b)
RoE = 31.20% (Net Income TTM 11.99b / Total Stockholder Equity 38.42b)
RoCE = 29.53% (EBIT 19.53b / Capital Employed (Equity 38.42b + L.T.Debt 27.74b))
RoIC = 19.91% (NOPAT 12.93b / Invested Capital 64.93b)
WACC = 5.14% (E(88.95b)/V(120.24b) * Re(6.59%) + D(31.28b)/V(120.24b) * Rd(1.55%) * (1-Tc(0.34)))
Discount Rate = 6.59% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 79.32% ; FCFE base≈6.68b ; Y1≈7.18b ; Y5≈8.81b
Fair Price DCF = 225.1 (DCF Value 153.87b / Shares Outstanding 683.5m; 5y FCF grow 8.49% → 3.0% )
EPS Correlation: -61.35 | EPS CAGR: -56.10% | SUE: -0.51 | # QB: 0
Revenue Correlation: 70.39 | Revenue CAGR: 15.81% | SUE: 0.69 | # QB: 0
Additional Sources for SBS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle